|1||NCT00478426||Active, not recruiting||Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer||
||30||Female||18 Years and older (Adult, Older Adult)||NCT00478426||NCI-2009-00210
|April 30, 2007||January 31, 2019||May 24, 2007||February 6, 2019||
|2||NCT02465060||Recruiting||Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)||
||6452||All||18 Years and older (Adult, Older Adult)||NCT02465060||NCI-2015-00054
|August 12, 2015||June 30, 2022||June 8, 2015||September 20, 2019||
† Study has passed its completion date and status has not been verified in more than two years.